Javascript must be enabled to continue!
How Well Does a Student-Run Free Clinic Care for Diabetic Patients?
View through CrossRef
Background: Student-run free clinics are an integral safety net for the uninsured, particularly for managing chronic conditions such as diabetes. A previous study of diabetes care at the East Harlem Health Outreach Partnership (EHHOP) demonstrated that patients receive comparable care to insured patients. In this study we explore the clinic’s achievement and maintenance of glycemic targets in adult type II diabetes patients.Methods: This was a retrospective study examining hemoglobin A1c (A1c) values from 2009-2012. Patients with baseline A1c ≥7.0% and ≥2 A1c values recorded were included in this study. Data was analyzed at baseline, 6 months, 1 and 2 years from diagnosis, and at final recorded visit. Prescribed medications were also assessed. Results were compared with other published diabetes quality-of-care metrics.Results: Forty-four patients met entry criteria. Mean baseline A1c was 10.1%±2.3% and decreased to 8.3±2.3% by 6 months of treatment. By their final visit, 40.9% (n=18) of patients achieved an American Diabetes Association A1c goal of ≤7.0%. Of those patients with A1c values above target, 15 reduced their A1c to ≤8.0%. Patients whose A1c values reached ≤7.0% maintained stable low A1c levels for the remainder of follow-up. Over 90% of patients achieved targets with ≥1 hypoglycemic medication. Patients least able to achieve goal A1c were more likely to take a greater number of medications. These results are comparable to other published metrics.Conclusions: Despite resource limitations, uninsured patients at student-run free clinics are able to reach and maintain target A1c at comparable rates to their insured counterparts.
Society of Student Run Free Clinics
Title: How Well Does a Student-Run Free Clinic Care for Diabetic Patients?
Description:
Background: Student-run free clinics are an integral safety net for the uninsured, particularly for managing chronic conditions such as diabetes.
A previous study of diabetes care at the East Harlem Health Outreach Partnership (EHHOP) demonstrated that patients receive comparable care to insured patients.
In this study we explore the clinic’s achievement and maintenance of glycemic targets in adult type II diabetes patients.
Methods: This was a retrospective study examining hemoglobin A1c (A1c) values from 2009-2012.
Patients with baseline A1c ≥7.
0% and ≥2 A1c values recorded were included in this study.
Data was analyzed at baseline, 6 months, 1 and 2 years from diagnosis, and at final recorded visit.
Prescribed medications were also assessed.
Results were compared with other published diabetes quality-of-care metrics.
Results: Forty-four patients met entry criteria.
Mean baseline A1c was 10.
1%±2.
3% and decreased to 8.
3±2.
3% by 6 months of treatment.
By their final visit, 40.
9% (n=18) of patients achieved an American Diabetes Association A1c goal of ≤7.
0%.
Of those patients with A1c values above target, 15 reduced their A1c to ≤8.
0%.
Patients whose A1c values reached ≤7.
0% maintained stable low A1c levels for the remainder of follow-up.
Over 90% of patients achieved targets with ≥1 hypoglycemic medication.
Patients least able to achieve goal A1c were more likely to take a greater number of medications.
These results are comparable to other published metrics.
Conclusions: Despite resource limitations, uninsured patients at student-run free clinics are able to reach and maintain target A1c at comparable rates to their insured counterparts.
Related Results
Diabetic Foot in Qatar: A Primary Care Perspective
Diabetic Foot in Qatar: A Primary Care Perspective
Diabetic Foot in QatarA primary care Perspective Introduction Diabetes represents a major public health burden in developing countries, especially the Arabian Gulf region, which is...
Renal biopsy in diabetic patients: Histopathological and clinical correlations
Renal biopsy in diabetic patients: Histopathological and clinical correlations
Introduction: Diabetes is the leading cause of chronic kidney disease and end-stage kidney disease worldwide. A kidney biopsy in a diabetic patient must be considered when non-diab...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Impact of Diabetic Neuropathy on Ankle Dorsiflexion in Older Adults
Impact of Diabetic Neuropathy on Ankle Dorsiflexion in Older Adults
Background: Diabetes mellitus is increasing among the population. If early diagnosis and treatment can be done, complications can be reduced. Although there are studies evaluating ...
GW24-e3068 The risk factors analysis and follow-up study of prehypertensive diabetic patients
GW24-e3068 The risk factors analysis and follow-up study of prehypertensive diabetic patients
Objectives
To analyse the prevalence and risk factors of prehypertension among normal blood pressure diabetic patients. To assess the renal function of prehyperte...
A Comparative Change in Left Ventricular Mass Index on Echocardiography in Hypertensive Diabetic and Non-Diabetic Patients Taking Candesartan
A Comparative Change in Left Ventricular Mass Index on Echocardiography in Hypertensive Diabetic and Non-Diabetic Patients Taking Candesartan
Background: To assess the evolution of the left ventricular mass index on echocardiography in candesartan-treated hypertension individuals with and without diabetes. Study Design: ...
SERUM VISFATIN, INSULIN RESISTANCE AND BETA CELL FUNCTION IN TYPE II DIABETIC PATIENTS AND NON-DIABETIC ADULT OFFSPRING WITH POSITIVE PARENTAL HISTORY OF TYPE II DIABETES MELLITUS
SERUM VISFATIN, INSULIN RESISTANCE AND BETA CELL FUNCTION IN TYPE II DIABETIC PATIENTS AND NON-DIABETIC ADULT OFFSPRING WITH POSITIVE PARENTAL HISTORY OF TYPE II DIABETES MELLITUS
Introduction:
Non-diabetic individuals with type II diabetic parents are more susceptible to develop Diabetes. Visfatin; an adipocytokine and an enzyme is linked with glucose...

